245 related articles for article (PubMed ID: 8730489)
21. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy.
Mazzaro C; Franzin F; Tulissi P; Pussini E; Crovatto M; Carniello GS; Efremov DG; Burrone O; Santini G; Pozzato G
Cancer; 1996 Jun; 77(12):2604-13. PubMed ID: 8640712
[TBL] [Abstract][Full Text] [Related]
22. The natural history of cryoglobulinemia: symptoms at onset and during follow-up. A report by the Italian Group for the Study of Cryoglobulinemias (GISC).
Monti G; Saccardo F; Pioltelli P; Rinaldi G
Clin Exp Rheumatol; 1995; 13 Suppl 13():S129-33. PubMed ID: 8730493
[TBL] [Abstract][Full Text] [Related]
23. Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection.
Wong VS; Egner W; Elsey T; Brown D; Alexander GJ
Clin Exp Immunol; 1996 Apr; 104(1):25-31. PubMed ID: 8603528
[TBL] [Abstract][Full Text] [Related]
24. Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group.
Cacoub P; Musset L; Amoura Z; Guilani P; Chabre H; Lunel F; Poynard T; Opolon P; Piette JC
J Rheumatol; 1997 Nov; 24(11):2139-44. PubMed ID: 9375873
[TBL] [Abstract][Full Text] [Related]
25. [Hepatitis C virus and mixed cryoglobulinemia in dialysis].
Colombo P; Cascina A; Monzeglio C; Costantini L; Porcu M; Filiberti O; Peona C
Minerva Urol Nefrol; 1997 Sep; 49(3):109-13. PubMed ID: 9432731
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of hepatitis C virus associated cryoglobulinemia at a veterans hospital.
Kerr GS; Rofail M; Lewis JH; Kumar P; Seeff LB
J Rheumatol; 1997 Nov; 24(11):2134-8. PubMed ID: 9375872
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia.
Dammacco F; Sansonno D
Clin Exp Immunol; 1992 Mar; 87(3):352-6. PubMed ID: 1311992
[TBL] [Abstract][Full Text] [Related]
28. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
Luppi M; Grazia Ferrari M; Bonaccorsi G; Longo G; Narni F; Barozzi P; Marasca R; Mussini C; Torelli G
Leukemia; 1996 Feb; 10(2):351-5. PubMed ID: 8637247
[TBL] [Abstract][Full Text] [Related]
30. Cryoglobulinaemia and autoimmune markers in hepatitis C virus infected patients on renal replacement therapy.
Anis S; Muzaffar R; Ahmed E; Ali S; Nadir A; Naqvi A; Rizvi AH
J Pak Med Assoc; 2007 May; 57(5):225-9. PubMed ID: 17571476
[TBL] [Abstract][Full Text] [Related]
31. Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia.
Ferri S; Dal Pero F; Bortoletto G; Bianchi FB; Lenzi M; Alberti A; Gerotto M
J Viral Hepat; 2006 Mar; 13(3):166-76. PubMed ID: 16475992
[TBL] [Abstract][Full Text] [Related]
32. Anti-GOR antibodies, HCV, liver disease and cryoglobulinemia.
Saccardo F; Monti G; Rinaldi G; Pioltelli P; Mosconi L; Garelli G
Clin Exp Rheumatol; 1995; 13 Suppl 13():S165-6. PubMed ID: 8730500
[TBL] [Abstract][Full Text] [Related]
33. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia.
Sansonno D; Cornacchiulo V; Iacobelli AR; Di Stefano R; Lospalluti M; Dammacco F
Hepatology; 1995 Feb; 21(2):305-12. PubMed ID: 7843698
[TBL] [Abstract][Full Text] [Related]
34. Association between hepatitis C virus and mixed cryoglobulinemia [see comment].
Ferri C; Greco F; Longombardo G; Palla P; Moretti A; Marzo E; Mazzoni A; Pasero G; Bombardieri S; Highfield P
Clin Exp Rheumatol; 1991; 9(6):621-4. PubMed ID: 1662567
[TBL] [Abstract][Full Text] [Related]
35. Clinical image: cutaneous ulceration in type II cryoglobulinemia.
Wisnieski JJ; Breen BS
Arthritis Rheum; 1998 May; 41(5):868. PubMed ID: 9588739
[No Abstract] [Full Text] [Related]
36. The association of hepatitis C virus infection with monoclonal rheumatoid factors bearing the WA cross-idiotype: implications for the etiopathogenesis and therapy of mixed cryoglobulinemia.
Agnello V; Zhang QX; Abel G; Knight GB
Clin Exp Rheumatol; 1995; 13 Suppl 13():S101-4. PubMed ID: 8730487
[TBL] [Abstract][Full Text] [Related]
37. Primary, post-primary and non-specific immunoglobulin M responses in HCV infection.
Dustin LB; Charles ED
Antivir Ther; 2012; 17(7 Pt B):1449-52. PubMed ID: 23322600
[TBL] [Abstract][Full Text] [Related]
38. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.
Misiani R; Bellavita P; Fenili D; Vicari O; Marchesi D; Sironi PL; Zilio P; Vernocchi A; Massazza M; Vendramin G
N Engl J Med; 1994 Mar; 330(11):751-6. PubMed ID: 8107741
[TBL] [Abstract][Full Text] [Related]
39. Hypocomplementemia associated with hepatitis C viremia in sera from voluntary blood donors.
Itoh K; Tanaka H; Shiga J; Hirakawa K; Akahane Y; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
Am J Gastroenterol; 1994 Nov; 89(11):2019-24. PubMed ID: 7524311
[TBL] [Abstract][Full Text] [Related]
40. High prevalence of hepatitis C virus RNA in the supernatant and the cryoprecipitate of patients with essential and secondary type II mixed cryoglobulinemia.
Bichard P; Ounanian A; Girard M; Baccard C; Rolachon A; Renversez JC; Cordonnier D; Seigneurin JM; Debru JL; Zarski JP
J Hepatol; 1994 Jul; 21(1):58-63. PubMed ID: 7525697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
